Influence of Antiplatelet Medications on Bleeding Events in Hemodialysis Patients

Therapeutic Apheresis and Dialysis

Volumn 15, Issue 5, 2011, Pages 454-459

  Daimon, Shoichiro ^a   Terai, Hidenobu ^b  

^a Daimon Clinic for Internal Medicine   (Japan)

^b Cardio Vascular Center Kanazawa Circulation Hospital   (Japan)

Author keywords

Antiplatelet medication; Bleeding; Diabetes mellitus; Hemodialysis

Indexed keywords

ACETYLSALICYLIC ACID; CILOSTAZOL; CLOPIDOGREL; HEPARIN; SARPOGRELATE; TICLOPIDINE; WARFARIN;

ADULT; AGED; ARTICLE; BLEEDING; BRAIN HEMORRHAGE; BRAIN INFARCTION; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; RETINA HEMORRHAGE; TREATMENT DURATION; VITREOUS HEMORRHAGE;

AGED; AGED, 80 AND OVER; DIABETES MELLITUS; FEMALE; HEMORRHAGE; HUMANS; ISCHEMIA; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; RENAL DIALYSIS; RETROSPECTIVE STUDIES; THROMBOSIS; TIME FACTORS;

EID: 80955180929     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/j.1744-9987.2011.00935.x     Document Type: Article

References (21)

1. Derry S, Loke YK. Risk of gastrointestinal haemorrhage with long term-use of aspirin: meta analysis. BMJ 2000;321:1183-7.
2. Steinhubl SR, Bhatt DL, Brennan BM etal. Aspirin to prevent cardiovascular disease: the association of aspirin dose and clopidogrel with thrombosis and bleeding. Ann Intern Med 2009;150:379-86.
3. Leon MB, Baim DS, Popma JJ etal. A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. N Engl J Med 1998;339:1665-71.
4. Mehta SR, Yusuf S, Peters RJG etal. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet 2001;358:527-33.
5. Bhatt DL, Fox KAA, Hacke W etal. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med 2006;354:1706-17.
6. Kaw D, Malhotra D. Platelet dysfunction and end-stage renal disease. Semin Dial 2006;19:317-22.
7. Jaminidar PKB. Chapter 26: Gastrointestinal Disease in Patients with Chronic Renal Failure. In: Nissenson AR, Fine RN, Gentile DE, eds. Clinical Dialysis vol. 3, 3rd edn. East Norwalk: Appleton & Lange, 1995;607-17.
8. Iseki K, Kinjo K, Kimura Y etal. Evidence for high risk of cerebral haemorrhage in chronic dialysis patients. Kidney Int 1993;44:1086-90.
9. Lohr J, Schwab S. Minimizing hemorrhagic complications in dialysis patients. J Am Soc Nephrol 1991;2:961-75.
10. Sreedhara R, Himmelfarb J, Azarus J, Hakim R. Antiplatelet therapy in expanded polytetrafluoroethylene (ePTEE) graft thrombosis: results of a prospective, randomized double-blind study. Kidney Int 1994;45:1477-83.
11. Kaufman JS, O'connor TZ, Zhang JH etal. Randomized controlled trial of clopidogrel plus aspirin to prevent hemodialysis access thrombosis. J Am Soc Nephrol 2003;14:2313-21.
12. Dember LM, Beck GJ, Allon M etal. for the Dialysis Access Consortium Study Group. Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis. JAMA 2008;299:2164-71.
13. Dennis VW. Coronary heart disease in patients with chronic kidney disease. J Am Soc Nephrol 2005;16:S103-106.
14. Ohtake T, Kobayashi S, Moriya H etal. High prevalence of occult coronary artery stenosis in patients with chronic kidney disease at the initiation of renal replacement therapy: an angiographic examination. J Am Soc Nephrol 2005;16:1141-8.
15. Hiremath S, Holden RM, Fergusson D etal. Antiplatelet medications in hemodialysis patients: a systemic review of bleeding rates. Clin J Am Soc Nephrol 2009;4:1347-55.
16. Livio M, Benigni A, Vigano G etal. Moderate doses of aspirin and risk of bleeding in renal failure. Lancet 1986;1:414-16.
17. Limdi NA, Limdi MA, Cavallari L etal. Warfarin dosing in patients with impaired kidney function. Am J Kidney Dis 2010;56:823-31.
18. Tordoir JH, Bode AS, Peppelenbosch N etal. Surgical or endovascular repair of thrombosed dialysis vascular access: is there any evidence? J Vasc Surg 2009;50:953-6.
19. Moses JW, Leon MB, Popma JJ etal. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery disease. N Engl J Med 2003;349:1315-23.
20. Stone GW, Ellis SG, Cox DA etal. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 2004;350:221-31.
21. Iakovou I, Schmidt T, Bonizzoni E etal. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005;293:2126-30.